Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Increasing sales is vital for profitability. Learn effective techniques to boost sales and enhance your profits.
28,655 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
VOO has delivered outsized gains over the last decade, returning 281% over years. Yet a heavy tilt to mega-cap tech a...
Emerging market small caps are posting growing trailing dividends despite volatile quarterly payments, helping them b...
Peter Thiel leads a $140 million round for Panthalassa, a wave-powered data-center venture aiming to scale floating c...
Meta Platforms delivered a powerful Q1 2026, with revenue surging and AI investment plans outlined, prompting investo...
As markets swing in May 2026, PJUL caps your gains at a defined ceiling while protecting against early losses, a path...
Bitcoin again hovers near the 70K mark as XRP mirrors BTC moves. A test of AI forecasting asks what XRP bottoms could...
In 2026, corporate bond spreads tightening is reshaping risk and return for the iShares LQD ETF, as yields, credit qu...
A 64-year-old retired teacher with a $1.1M 403(b) and a state pension confronts higher Medicare IRMAA surcharges as M...
A Wall Street note imagines a SpaceX IPO delivering about 40% upside, powered by a diversified revenue mix. This repo...
Income-focused investors are turning to monthly dividend ETFs yielding strong cash flow in 2026. Four funds stand out...
A new funding framework could let Ethereum validators redirect up to 10% of staking rewards to ecosystem projects, bu...